N. Oliver

发表

Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors

E D Blair, R. Myers, B. Maschera, 1995, Antimicrobial agents and chemotherapy.

Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir.

B. Larder, G. Darby, P. Collins, 1989, The Journal of general virology.

Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir.

P. Collins, N. Oliver, 1986, The Journal of antimicrobial chemotherapy.

ACYCLOVIR-RESISTANT HERPES SIMPLEX VIRUS INFECTION DUE TO ALTERED DNA POLYMERASE

J. Craig, N. Oliver, I. Smith, 1987, The Lancet.

ACYCLOVIR-RESISTANT HERPES IN AIDS TREATED WITH FOSCARNET

D. Shanson, N. Oliver, P. Collins, 1988, The Lancet.

Sensitivity of herpes virus isolates from acyclovir clinical trials.

G. Appleyard, P. Collins, N. Oliver, 1982, The American journal of medicine.

Acyclovir treatment of cutaneous herpes in guinea pigs and herpes encephalitis in mice.

P. Collins, N. Oliver, 1982, American Journal of Medicine.

Comparison of the in vitro and in vivo antiherpes virus activities of the acyclic nucleosides, acyclovir (Zovirax) and 9-[(2-hydroxy-1-hydroxymethylethoxy)methyl]guanine (BWB759U).

P. Collins, N. Oliver, 1985, Antiviral research.

Biological and biochemical characterization of clinical isolates of herpes simplex virus type 2 resistant to acyclovir

J. V. D. van der Meer, P. Collins, N. Oliver, 1989, Antimicrobial Agents and Chemotherapy.